EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT

被引：0

作者：

Gomez-Dominguez, Elena ^{[1
]}

Montero, Jose-Luis ^{[2
]}

Molina, Esther ^{[3
]}

Casado, Marta

Garcia-Buey, Maria Luisa ^{[4
]}

Simon, Miguel Angel ^{[5
]}

Fuentes, Javier ^{[6
]}

Diaz-Gonzalez, Alvaro ^{[7
]}

Berenguer, Marina ^{[8
]}

Conde, Isabel ^{[9
]}

Garrido, Isabel ^{[10
]}

Macedo, Guilherme ^{[10
]}

Jorquera, Francisco ^{[11
]}

Morillas, Rosa Maria ^{[12
]}

Presa, Jose Antonio ^{[13
]}

Rodriguez-Tajes, Sergio ^{[14
]}

Olivas, Ignasi ^{[15
]}

Londono, Maria Carlota ^{[14
]}

Ampuero, Javier ^{[16
,17
]}

Romero-Gonzalez, Eva ^{[18
]}

Gonzalez-Padilla, Sheila ^{[18
]}

Escudero-Garcia, Desamparados ^{[18
]}

Martin, Jose Manuel Sousa

Gomes, Dario Lorga ^{[19
]}

Santos, Luis

Olveria, Antonio ^{[20
]}

Hernandez-Guerra, Manuel ^{[21
]}

Santos, Manuel A. ^{[22
]}

Carvalho, Armando S. P.

Uriz, Juan

Gutierrez, Maria Luisa ^{[23
]}

Quinones, Marta ^{[23
]}

Perez, Elia ^{[23
]}

Martinez, Javier ^{[24
]}

Albillos, Agustin ^{[25
,26
]}

Fernandez-Rodriguez, Conrado ^{[23
,27
]}

机构：

[1] Hosp Univ 12 Octubre, Madrid, Spain

[2] Hosp Univ Reina Sofia, Cordoba, Spain

[3] Complexo Hosp Univ Santiago, Coruna, Spain

[4] Hosp Univ Princesa, Madrid, Spain

[5] Hosp Univ Lozano Blesa, Zaragoza, Spain

[6] Hosp Univ Miguel Servet, Zaragoza, Spain

[7] Hosp Univ Marques Valdecilla, Santander, Spain

[8] Univ Valencia, Hosp Univ La Fe, Valencia, Spain

[9] Hosp Univ Fe, Valencia, Spain

[10] Ctr Hosp Univ S Joao, Porto, Portugal

[11] Complejo Hosp Leon, Leon, Spain

[12] Hosp Germans Trias Pujol, Barcelona, Spain

[13] Ctr Hosp Tras Os Montes E Alto Douro, Vila Real, Portugal

[14] Hosp Clin Barcelona, Barcelona, Spain

[15] Hosp Clin Barcelona, Barcelona, Spain

[16] Virgen Rocio Univ Hosp, Seville, Spain

[17] Inst Biomed Sevilla IBIS, Seville, Spain

[18] Hosp Clin Univ Valencia, Valencia, Spain

[19] Ctr Hosp Univ Coimbra, Coimbra, Portugal

[20] Hosp Univ La Paz, Madrid, Spain

[21] Hosp Univ Canarias, Tenerife, Spain

[22] Ctr Hosp & Univ Coimbra, Coimbra, Portugal

[23] Hosp Univ Fdn Alcorcon, Madrid, Spain

[24] Hosp Univ Ramon y Cajal, Madrid, Spain

[25] Ramon y Cajal Inst Hlth Res, Madrid, Spain

[26] Univ Alcala Henares, Madrid, Spain

[27] Univ Rey Juan Carlos, Madrid, Spain

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

116

引用

页码：S116 / S117

页数：2

共 50 条

[21] Relationship between Diabetes Duration and Real-World Effectiveness of Second-Line Dual OAD Therapy
Brath, Helmut
Paldanius, Paeivi M.
Bader, Giovanni
Mathieu, Chantal
DIABETES, 2015, 64 : A315 - A316
[22] Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort
Wiegand, Johannes
Franke, Annegret
Mueller, Tobias
Stein, Kerstin
Bantel, Heike
Guenther, Rainer
Denk, Gerald
Reuken, Philipp A.
Schattenberg, Joern M.
Naumann, Uwe
Boettler, Tobias
Weber, Andreas
Zeuzem, Stefan
Hinz, Matthias
Greinert, Robin
Berg, Christoph
Wissniowski, Thaddaeus Till
Simon, Karl-Georg
Trebicka, Jonel
Behrens, Ruediger
Gruemmer, Harald
Hofmann, Wolf Peter
Dikopoulos, Nektarios
Sarrazin, Christoph
Roeb, Elke
Kremer, Andreas E.
Muche, Marion
Ringelhan, Marc
Teufel, Andreas
Michl, Patrick
Keitel, Verena
Marquardt, Jens U.
Kautz, Achim
Tacke, Frank
Piotrowski, Katja
Koeppe-Bauernfeind, Nicole
Trautwein, Christian
Berg, Thomas
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (11): : 1931 - 1942
[23] Sub-optimal therapy of patients with primary biliary cholangitis (PBC) in the real-life stetting of the German PBC cohort
Wiegand, Johannes
Franke, Annegret
Mueller, Tobias
Stein, Kerstin
Bantel, Heike
Guenther, Rainer
Denk, Gerald
Reuken, Philipp A.
Schattenberg, Joern M.
Naumann, Uwe
Boettler, Tobias
Weber, Andreas
Zeuzem, Stefan
Hinz, Matthias
Greinert, Robin
Berg, Christoph
Wissniowski, Thaddaeus Till
Simon, Karl-Georg
Trebicka, Jonel
Behrens, Ruediger
Gruemmer, Harald
Hofmann, Wolf Peter
Dikopoulos, Nektarios
Sarrazin, Christoph
Roeb, Elke
Kremer, Andreas E.
Muche, Marion
Ringelhan, Marc
Teufel, Andreas
Michl, Patrick
Keitel, Verena
Marquardt, Jens U.
Kautz, Achim
Tacke, Frank
Piotrowski, Katja
Koeppe-Bauernfeind, Nicole
Trautwein, Christian
Berg, Thomas
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (11): : 1931 - 1942
[24] Effectiveness, safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.
Ferreira, S.
Parra, R. Serafim
Sassaki, L. Yukie
Parente, J. M. Luz
de Mello, M. Kurtz
Chebli, L. Andrade
Luporini, R. L.
Alves Junior, A. J. Tiburcio
Nobrega, F. J. Firmino
da Silva, B. C.
Miranda, E. F.
Quaresma, A. Botelho
Nicollelli, G. Mattioli
Gasparini, R. Galhardi
Dutra, R. de Medeiros
da Silva, K. da Conceicao
Magro, D. Oliveira
Imbrizi, M. R.
Nagasako, C. Kibune
Feres, O.
Troncon, L. E. de Almeida
Kotze, P. G.
Chebli, J. M. Fonseca
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1335 - i1336
[25] Treatment of Primary Biliary Cholangitis First-Line and Second-Line Therapies
Liu, Chung-Heng
Bowlus, Christopher L.
CLINICS IN LIVER DISEASE, 2022, 26 (04) : 705 - 726
[26] EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
Ganti, A. K.
Allan, V.
Merola, D.
Estrin, A.
Boccuti, A.
Rengarajan, B.
Baratta, C.
Prince, P.
Li, W.
Cao, Y.
D'Agostino, R. B., Jr.
Poole, E. M.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S378 - S379
[27] BEZAFIBRATE AS SECOND LINE TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: A REAL WORLD EXPERIENCE
McCabe, Rebecca
Prince, Martin
Greer, Shaun
Dhaliwal, Harpreet
GUT, 2021, 70 : A147 - A147
[28] Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis
Cumpian, Nicholas A.
Choi, Gina
Saab, Sammy
DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (01) : 100 - 110
[29] Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
Reig, Anna
Alvarez-Navascues, Carmen
Vergara Gomez, Mercedes
Gomez Dominguez, Elena
Gallego Moya, Adolfo
Perez-Medrano, Indhira
Fabrega, Emilio
Hernandez Guerra, Manuel
Berenguer Haym, Marina
Estevez, Pamela
Arencibia Almeida, Ana
Morillas, Rosa
Horta, Diana
Albillos, Agustin
Casado, Marta
De la Cruz, Gemma
Fernandez Bonilla, Eva
Molina, Esther
Hijona, Lander
Diago, Moises
Fernandez Rodriguez, Conrado Manuel
Gonzalez-Santiago, Jesus M.
Sala, Margarita
Gomez-Camarero, Judith
Romero Gomez, Manuel
Suarez, Francisco
Vargas Blasco, Victor Manuel
Ferre Aracil, Carlos
Andrade, Raul J.
Chahri, Nadia
Pares, Albert
JOURNAL OF HEPATOLOGY, 2020, 73 : S460 - S461
[30] The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus
Martellino, Chiara
Lagana, Angelina
Atanasio, Giorgia
Lamanna, Fabio
Attardo, Silvia
Cascino, Simona
De Luca, Marcella
Pardeo, Orazio
Giacobbe, Giuseppa
Tripepi, Giovanni
Roberti, Roberta
Granata, Francesca
Morace, Carmela
Russo, Emilio
Labate, Angelo
EPILEPSY & BEHAVIOR, 2023, 148

← 1 2 3 4 5 →